Treatment for AR includes topical corticosteroids, topical antihistamines, oral nonsedating histamine 1 antihistamines, reduction of allergen exposure, and allergen-specific immunotherapy
Risk factors for AR include environmental factors, genetic predisposition, atopic dermatitis, family history of AR, heavy outdoor air pollution, tobacco smoke exposure, and being born during pollen season
High prevalence of AR leads to impaired quality of life, high treatment costs, presence of comorbidities like asthma and otitis media, and decreased workplace productivity
Diagnostic tests for AR include skin prick testing, measurement of allergen-specific IgE in serum and nasal lavage, and a thorough history and physical examination
Drug treatment for AR aims to alleviate symptoms like nasal obstruction, rhinorrhea, sneezing, and nasal itching, with intranasal steroids being the most effective class of medication
Intranasal steroids are considered first-line treatment for AR and are effective for all symptoms, including those affecting the eyes in patients with allergic conjunctivitis
Oral antihistamines are effective for nasal and ocular symptoms, while leukotriene-receptor antagonists are suitable for severe congestion not responding to steroids